Alessio Mazzoni to Female
This is a "connection" page, showing publications Alessio Mazzoni has written about Female.
Connection Strength
0.054
-
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19. J Clin Invest. 2021 06 15; 131(12).
Score: 0.013
-
Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients. Eur J Immunol. 2020 Dec; 50(12):2013-2024.
Score: 0.012
-
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
Score: 0.012
-
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab. PLoS Pathog. 2021 02; 17(2):e1009243.
Score: 0.003
-
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett. 2020 12; 228:122-128.
Score: 0.003
-
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection. Immunology. 2020 12; 161(4):345-353.
Score: 0.003
-
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
Score: 0.003
-
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
Score: 0.003
-
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FceRI. Eur J Immunol. 2018 12; 48(12):2005-2014.
Score: 0.003